Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Functional polymorphisms in the promoters of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12 and MMP-13 are not associated with hepatocellular carcinoma risk.

Zhai Y, Qiu W, Dong XJ, Zhang XM, Xie WM, Zhang HX, Yuan XY, Zhou GQ, He FC.

Gut. 2007 Mar;56(3):445-7. No abstract available.

2.

No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population.

Qiu W, Zhou G, Zhai Y, Zhang X, Xie W, Zhang H, Yang H, Zhi L, Yuan X, Zhang X, He F.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2514-8. doi: 10.1158/1055-9965.EPI-08-0557.

3.

Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene.

Ho SY, Wang YJ, Chen HL, Chen CH, Chang CJ, Wang PJ, Chen HH, Guo HR.

Cancer Causes Control. 2004 Sep;15(7):657-63.

PMID:
15280623
4.

MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation.

Wu LM, Zhang F, Xie HY, Xu X, Chen QX, Yin SY, Liu XC, Zhou L, Xu XB, Sun YL, Zheng SS.

Clin Genet. 2008 Mar;73(3):273-8. doi: 10.1111/j.1399-0004.2007.00955.x. Epub 2008 Jan 3.

PMID:
18177474
5.

Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.

Li Y, Jin X, Kang S, Wang Y, Du H, Zhang J, Guo W, Wang N, Fang S.

Gynecol Oncol. 2006 Apr;101(1):92-6. Epub 2005 Nov 8.

PMID:
16278009
6.

The association of MMP-1, -3 and -9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients.

Okamoto K, Mandai M, Mimura K, Murawaki Y, Yuasa I.

Res Commun Mol Pathol Pharmacol. 2005;117-118:77-89.

PMID:
18426080
8.
9.

TNFalpha promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population.

Jung KW, Ha E, Yu GI, Kim SJ, Chung WJ, Jang BK, Lee JJ, Shin DH, Hwang JS.

Clin Chim Acta. 2009 Sep;407(1-2):16-9. doi: 10.1016/j.cca.2009.06.013. Epub 2009 Jun 21.

PMID:
19545551
10.

Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.

Chen CC, Yang SY, Liu CJ, Lin CL, Liaw YF, Lin SM, Lee SD, Chen PJ, Chen CJ, Yu MW.

Int J Epidemiol. 2005 Dec;34(6):1310-8. Epub 2005 Sep 19.

PMID:
16172101
11.

A novel functional polymorphism in the Cdc6 promoter is associated with the risk for hepatocellular carcinoma.

Xiong XD, Fang JH, Qiu FE, Zhao J, Cheng J, Yuan Y, Li SP, Zhuang SM.

Mutat Res. 2008 Aug 25;643(1-2):70-4. doi: 10.1016/j.mrfmmm.2008.06.006. Epub 2008 Jul 1.

PMID:
18640135
12.

Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer.

Elander N, Söderkvist P, Fransén K.

Anticancer Res. 2006 Jan-Feb;26(1B):791-5.

13.

-509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.

Qi P, Chen YM, Wang H, Fang M, Ji Q, Zhao YP, Sun XJ, Liu Y, Gao CF.

Cancer Immunol Immunother. 2009 Sep;58(9):1433-40. doi: 10.1007/s00262-009-0660-4. Epub 2009 Jan 25.

PMID:
19169878
14.
15.

Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.

Hirata H, Okayama N, Naito K, Inoue R, Yoshihiro S, Matsuyama H, Suehiro Y, Hamanaka Y, Hinoda Y.

Carcinogenesis. 2004 Dec;25(12):2379-84. Epub 2004 Aug 19.

PMID:
15319295
16.

Association between IL-6 and MMP-3 gene polymorphisms and adolescent idiopathic scoliosis: a case-control study.

Aulisa L, Papaleo P, Pola E, Angelini F, Aulisa AG, Tamburrelli FC, Pola P, Logroscino CA.

Spine (Phila Pa 1976). 2007 Nov 15;32(24):2700-2.

PMID:
18007247
17.
18.

Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.

Nasr HB, Mestiri S, Chahed K, Bouaouina N, Gabbouj S, Jalbout M, Chouchane L.

Clin Chim Acta. 2007 Sep;384(1-2):57-63. Epub 2007 May 31.

PMID:
17599818
19.

[Study on the detoxication gene gstM1-gstT1-null and susceptibility to aflatoxin B1 related hepatocellular carcinoma in Guangxi].

Long XD, Ma Y, Wei YP, Deng ZL.

Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Oct;26(10):777-81. Chinese.

PMID:
16536303
20.

Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis.

Lichtinghagen R, Bahr MJ, Wehmeier M, Michels D, Haberkorn CI, Arndt B, Flemming P, Manns MP, Boeker KH.

Clin Sci (Lond). 2003 Sep;105(3):373-82.

PMID:
12760742

Supplemental Content

Support Center